A photo of Jessica A. Kahn.

Director and Rauh Chair, Division of Adolescent and Transition Medicine

Associate Chair, Academic Affairs and Career Development

Professor, UC Department of Pediatrics

513-636-8602

Board Certified

Best Doctors logo

My Biography & Research

Biography

Jessica A Kahn, MD, MPH, is a professor of pediatrics in the Division of Adolescent and Transition Medicine at Cincinnati Children's Hospital Medical Center within the University of Cincinnati College of Medicine in Cincinnati, Ohio. Dr. Kahn serves as the director of the Office of Academic Affairs and Career Development at Cincinnati Children’s. She also serves as the program director of the Cincinnati Center for Clinical and Translational Science and Training (CCTST) KL2 program at Cincinnati Children's and the University of Cincinnati College of Medicine. She is the President-Elect of the Society for Adolescent Health and Medicine.

Dr. Kahn sees primary care and consult patients at Cincinnati Children's Hospital Medical Center. Her clinical interests include sexual and reproductive health, eating disorders, and mental health disorders in adolescents. Her research program focuses on prevention of cervical cancer and other diseases caused by human papillomavirus.

Dr. Kahn received her undergraduate degree in architecture from Princeton University in Princeton, New Jersey in 1986. She received her MD from Harvard Medical School in Boston, Massachusetts in 1992 and her MPH from the Harvard School of Public Health in Boston, Massachusetts in 1999. She was chief resident in pediatrics and a fellow in adolescent medicine at the Children's Hospital in Boston, Massachusetts, as well as a clinical fellow and instructor at Harvard Medical School.

Dr. Kahn's research awards include the Huffman-Capraro Young Investigator Award from the North American Society for Pediatric and Adolescent Gynecology and the New Investigator Award from the Society for Adolescent Medicine. She has received research grants from the National Institutes of Health, the World Health Organization, and foundations such as the American Cancer Society. She has published more than 175 articles and is a contributing author for several medical textbooks. She has served on national and international committees and advisory groups focusing on vaccines and other adolescent health issues.

Additional Languages

Spanish

Clinical Interests

Primary care; sexual and reproductive health; eating disorders; mental health disorders

 

Research Interests

Interdisciplinary clinical and epidemiologic studies related to prevention of cervical cancer and other diseases caused by human papillomavirus (HPV)

Academic Affiliation

Professor, UC Department of Pediatrics

Divisions

Adolescent Medicine, Adolescent Medicine

Cincinnati Children's Blog

Preventing Infection

BlogResearch and Discoveries

Preventing Infection: An Update on the HPV Vaccine

By Jessica Kahn, MD, MPH11/23/2016

5 Things Parents Should Know About HPV Vaccines

BlogSafety and Prevention

5 Things Parents Should Know About HPV Vaccines

By Jessica Kahn, MD, MPH2/18/2014

Science Blog

Jessica Kahn to Direct Adolescent and Transition Medicine

Community Health

Jessica Kahn to Direct Adolescent and Transition Medicine

Jessica A. Kahn, MD, MPH7/1/2019

My Education

BArch: Princeton University, Princeton, NJ, 1986.

MD: Harvard Medical School, Boston, MA, 1992.

MPH: Harvard School of Public Health, Boston, MA, 1999.

Residency: Pediatrics, Children's Hospital, Boston, MA, 1995; Chief Resident, Pediatrics, Children's Hospital, Boston, MA, 1996.

Fellowship: Adolescent Medicine, Children's Hospital, Boston, MA, 1999.

Certification: American Board of Pediatrics, 1995; American Board of Pediatrics, subspecialist in Adolescent Medicine, 1999.

My Publications

Selected Publication

Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Drolet, M; Bénard, É; Pérez, N; Brisson, M; Ali, H; Boily, M; Baldo, V; Brassard, P; Brotherton, JM L; Callander, D; et al. The Lancet. 2019; 394:497-509.

Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction. Covert, C; Ding, L; Brown, D; Franco, EL; Bernstein, DI; Kahn, JA. Human Vaccines and Immunotherapeutics. 2019; 15:1962-1969.

Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women. Spinner, C; Ding, L; Bernstein, DI; Brown, DR; Franco, EL; Covert, C; Kahn, JA. Pediatrics. 2019; 143:e20181902-e20181902.

Faculty Members' Self-Awareness, Leadership Confidence, and Leadership Skills Improve after an Evidence-Based Leadership Training Program. Hackworth, J; Steel, S; Cooksey, E; DePalma, M; Kahn, JA. The Journal of Pediatrics. 2018; 199:4-6.e2.

Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction. Chandler, E; Ding, L; Gorbach, P; Franco, EL; Brown, DA; Widdice, LE; Bernstein, DI; Kahn, JA. Journal of Adolescent Health. 2018; 63:43-49.

HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination. Kahn, JA; Lee, J; Belzer, M; Palefsky, JM; Consortium, AI D S M; HIV, AM T N. AIDS and Behavior. 2018; 22:1826-1834.

Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection. Saccucci, M; Franco, EL; Ding, L; Bernstein, DI; Brown, D; Kahn, JA. Sexually Transmitted Diseases. 2018; 45:260-265.

Quality of Web-Based Educational Interventions for Clinicians on Human Papillomavirus Vaccine: Content and Usability Assessment. Rosen, BL; Bishop, JM; McDonald, SL; Kahn, JA; Kreps, GL. JMIR Cancer. 2018; 4:e3-e3.

Human Papillomavirus Vaccine-Related Risk Perceptions Do Not Predict Sexual Initiation Among Young Women Over 30 Months Following Vaccination. Mullins, TL K; Rosenthal, SL; Zimet, GD; Ding, L; Morrow, C; Huang, B; Kahn, JA. Journal of Adolescent Health. 2018; 62:164-169.

Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community. Kahn, JA; Widdice, LE; Ding, L; Huang, B; Brown, DR; Franco, EL; Bernstein, DI. Clinical Infectious Diseases. 2016; 63:1281-1287.